Eligibility Module
The Eligibility Module contains detailed information about who can participate in the clinical trial. This includes eligibility criteria, age restrictions, gender requirements, healthy volunteer status, and study population descriptions, helping researchers understand who is eligible to participate in the study.
Eligibility Module path is as follows:
Study -> Protocol Section -> Eligibility Module
Eligibility Module
Ignite Creation Date:
2025-12-24 @ 2:28 PM
Ignite Modification Date:
2025-12-24 @ 2:28 PM
NCT ID:
NCT00533559
Eligibility Criteria:
Inclusion Criteria:
Body mass index (BMI) \> 27kg/m2. Fasting triglycerides \> 2 mmol/l and \< 5mmol/l Waist circumference \> 90 cm Fasting blood glucose \< 7 mmol/l Hemoglobin above 130g/L.
Exclusion Criteria:
* History of hepatitis/hepatic disease that has been active within the previous two years
* any significant aactive disease of the gastrointestinal, pulmonary, neurological, renal, genitourinary,hematological systems or has severe uncontrolled treated or untreated hypertension or proliferative retinopathy
* fasting blood glucose \> 7mmol/l or known diabetes
* History of MI or clinically significant, active, cardiovascular history including a history of arrhythmia's or conduction delays on ECG, unstable angina, or hkeart failure
* any laboratory values\>2x the upper limit of normal
* known or suspected allergy to the mediction or a history of multiple and/or severe allergies to drugs or foods or a history of severe anaphylactic reactions, History of hypersensitivity to heparin
* current addiction to alcohol or substances of abuse as determined by the investigator
* Metal incapacity, unwillingness or language barrier precdluding adequate understanding or cooperation
* any lipid lowering or hypoglycemic agents
* previous history of asthma
* will not donate blood thre months prior to and three months post study procedures thrombocytopenis
Healthy Volunteers:
True
Sex:
MALE
Minimum Age:
35 Years
Maximum Age:
60 Years
Study:
NCT00533559
Study Brief:
Protocol Section:
NCT00533559